Related Experiment Videos
[Malignant melanoma: current survey: classification, prognostic factors, therapy guidelines]
Zeitschrift Fur Hautkrankheiten
|June 15, 1983
Summary
Predicting malignant melanoma (MM) progression is improving with statistical analysis. Early surgical removal is key, with tailored treatments for high-risk patients, including potential immunochemotherapy.
Area of Science:
- Oncology
- Dermatology
- Biostatistics
Context:
- Malignant melanoma (MM) classification and prognosis have advanced through statistical studies.
- Clinical staging (I-IV) aids in predicting MM behavior.
- Prognostic risk assessment utilizes clinical and histological criteria.
Purpose:
- To outline current understanding and treatment strategies for malignant melanoma based on prognostic risk.
- To evaluate the potential of early-stage immunochemotherapy and late-stage polychemotherapy for MM.
- To inform clinical decision-making for MM patients.
Summary:
- Early-stage MM (Stages I-II) requires prompt surgical excision.
- Treatment individualization based on prognostic risk is crucial.
- Preventive immunochemotherapy (e.g., BCG and dacarbazine) is under investigation for high-risk patients.
- Late-stage MM (Stages III-IV) shows limited response to current polychemotherapy.
Impact:
- Improved prediction of MM clinical course.
- Potential for more effective, personalized MM treatment strategies.
- Guidance for ongoing clinical trials in MM therapy.